Gauging the Success of Interventions for Depression Using Quality of Life By Dr. Aron Tendler, M.D., Chief Medical Officer, BrainsWay
Considering the high prevalence and disease burden of depression, researchers at BrainsWay and Ben Gurion University sought to shed light on the impact of quality of life for treatment-resistant depression patients following Deep Transcranial Magnetic Stimulation (Deep TMS™) therapy. They measured the effect of Deep TMS treatment on both symptom reduction and reported quality of life. Read more.